Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.57% | $1.41B | €458.38B | 86.92% | 76 Outperform | |
| Roche Holding AG | 2.01% | $798.45M | CHF268.16B | 29.32% | 73 Outperform | |
| HSBC Holdings | 1.91% | $758.60M | £219.84B | 52.09% | 80 Outperform | |
| Novartis AG | 1.80% | $713.30M | CHF232.19B | 30.93% | 80 Outperform | |
| AstraZeneca | 1.76% | $699.40M | $305.49B | 27.65% | 80 Outperform | |
| Nestlé SA | 1.53% | $604.61M | CHF201.30B | 0.07% | 71 Outperform | |
| Shell (UK) | 1.40% | $556.81M | £179.19B | 24.58% | 73 Outperform | |
| Siemens | 1.40% | $555.95M | €176.96B | 2.09% | 74 Outperform | |
| SAP SE | 1.30% | $514.34M | €193.11B | -29.30% | 66 Neutral | |
| Banco Santander | 1.20% | $474.19M | €146.91B | 62.23% | 73 Outperform |